BRPI0404999A - Derivados de tiazol - Google Patents

Derivados de tiazol

Info

Publication number
BRPI0404999A
BRPI0404999A BR0404999-3A BRPI0404999A BRPI0404999A BR PI0404999 A BRPI0404999 A BR PI0404999A BR PI0404999 A BRPI0404999 A BR PI0404999A BR PI0404999 A BRPI0404999 A BR PI0404999A
Authority
BR
Brazil
Prior art keywords
thiazole derivatives
derivatives
end products
advanced glycation
glycation end
Prior art date
Application number
BR0404999-3A
Other languages
English (en)
Inventor
Michelle D Hines
Brian C Jones
Original Assignee
Avon Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Prod Inc filed Critical Avon Prod Inc
Publication of BRPI0404999A publication Critical patent/BRPI0404999A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"DERIVADOS DE TIAZOL". Apresentam-se processos para melhorar a aparência da pele por administração tópica de derivados de tiazol que inibem a formação de produtos finais de glicação avançada, degradam reticulações associadas a produtos finais de glicação avançada e inibem a função da glicose oxidase. Também se apresentam composições cosméticas e farmacêuticas compreendendo os derivados de tiazol.
BR0404999-3A 2003-12-17 2004-11-16 Derivados de tiazol BRPI0404999A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/738,412 US20050137239A1 (en) 2003-12-17 2003-12-17 Thiazole derivatives

Publications (1)

Publication Number Publication Date
BRPI0404999A true BRPI0404999A (pt) 2005-08-30

Family

ID=34523171

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0404999-3A BRPI0404999A (pt) 2003-12-17 2004-11-16 Derivados de tiazol

Country Status (10)

Country Link
US (1) US20050137239A1 (pt)
EP (1) EP1543824A3 (pt)
JP (1) JP2005179341A (pt)
CN (1) CN1636563A (pt)
AR (1) AR045847A1 (pt)
AU (1) AU2004205185B2 (pt)
BR (1) BRPI0404999A (pt)
CA (1) CA2479432A1 (pt)
MX (1) MXPA04012364A (pt)
TW (1) TW200520783A (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2484342A1 (en) * 2005-07-29 2012-08-08 Shiseido Company, Limited Hair resiliency / body improver and hair cosmetic
GB0605949D0 (en) * 2006-03-24 2006-05-03 Quest Int Serv Bv Milk product for skin treatment
FR2918570B1 (fr) * 2007-07-09 2012-10-05 Engelhard Lyon DIGLYCATION DES AGEs.
DE102010012594A1 (de) * 2010-03-23 2011-09-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Thiazolderivaten
CA3054370A1 (en) * 2017-02-24 2018-08-30 Alzheon, Inc. Methods for treating neurodegenerative disorders
KR102076936B1 (ko) * 2019-08-12 2020-02-13 연세대학교 산학협력단 티아졸 또는 이의 염을 유효성분으로 포함하는 알러지성 질환 또는 아토피 피부염 예방 또는 치료용 조성물
CN115697979A (zh) 2020-04-24 2023-02-03 拜耳公司 作为用于免疫激活的dgkzeta抑制剂的取代的氨基噻唑类

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321372A (en) * 1980-06-16 1982-03-23 Pfizer Inc. Antiulcer thiazol-2-ylcarbamoyl-carboxylic acids, esters and amides
CA2210684C (en) * 1995-01-18 2008-01-15 Alteon Inc. Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
KR100766158B1 (ko) * 2000-01-19 2007-10-10 알테온 인크. 티아졸, 이미다졸 및 옥사졸 화합물, 및 단백질 노화와관련된 장애의 치료
MXPA02008276A (es) * 2000-02-23 2004-04-05 Alteon Inc Compuestos de tiazolio y tratamientos de trastornos asociados con el envejecimiento proteinico.
WO2001062247A1 (en) * 2000-02-25 2001-08-30 Avon Products, Inc. Topical compositions containing thiazolium compounds and methods of using same
EP1353676A4 (en) * 2000-12-29 2006-05-31 Alteon Inc METHOD FOR THE TREATMENT OF FIBROUS OR OTHER INDICATIONS

Also Published As

Publication number Publication date
EP1543824A3 (en) 2005-09-14
MXPA04012364A (es) 2005-06-22
JP2005179341A (ja) 2005-07-07
AR045847A1 (es) 2005-11-16
CA2479432A1 (en) 2005-06-17
EP1543824A2 (en) 2005-06-22
AU2004205185B2 (en) 2007-11-22
CN1636563A (zh) 2005-07-13
US20050137239A1 (en) 2005-06-23
TW200520783A (en) 2005-07-01
AU2004205185A1 (en) 2005-07-07

Similar Documents

Publication Publication Date Title
EP1570840A3 (en) Topical composition comprising n-acetylaldosamines or n-acetylamino acids
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
HU230005B1 (en) Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
WO2004021968A3 (en) Solution for ungual application
WO2005020877A3 (de) Verwendung von biotin oder einem biotinderivat zur aufhellung der haut und behandlung von altersflecken
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
WO2007120170A3 (en) Compositions and methods for treating gram positive bacterial infection in a mammalian subject
EA200970154A1 (ru) Косметические или дерматологические препараты, содержащие n-ацетилцистеин
WO2010053327A3 (ko) 신규 화합물인 r a m a l i n 및 그 용도
WO2006018454A3 (de) Kosmetische zubereitung mit hyaluronsäure und saponinen zur behandlung von hautalterungserscheinungen
WO2007007291A3 (en) Cosmetic makeup and/or care process
WO2007047431A3 (en) Sulfonyl-substituted aryl compounds as modulators of peroxisome proliferator activated receptors
BRPI0404999A (pt) Derivados de tiazol
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
WO2004009038A3 (de) Kosmetische zubereitungen mit antibakteriellen eigenschaften glyzyrrhetinsäure enthaltend
PT1809383E (pt) Composições cosméticas
BR0316493A (pt) ésteres de ácido aldÈnico, métodos para produzir os mesmos, e métodos para produzir ingredientes ativos farmacêuticos ligados a polissacarìdicos ou derivados polissacarìdeos sobre grupos amino livres
WO2003059875A3 (en) DERIVATIVES OF α-PHENYLTHIOCARBOXYLIC AND α-PHENYLOXY-CARBOXYLIC ACIDS USEFUL FOR THE TREATMENT OF DISEASES RESPONDING TO PPARα ACTIVATION
WO2007007287A3 (en) Cosmetic makeup and/or care process
BRPI0407652A (pt) método para acentuar a eficácia de um agente ativo, composição e método para produzir a composição
WO2004089329A3 (en) Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
AU6997200A (en) No-liberating topically applicable composition as biological agent, production and utilization thereof as dermatological and/or cosmetic product
WO2003105751A3 (en) NEW CURCUMIN DERIVATIVES
WO2007007292A3 (en) Cosmetic makeup and/or care product
CA2319849A1 (fr) Utilisation de complexes inorganiques-organiques dans une composition

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 19/08 (2006.01), A61K 8/49 (2006.01), A61K 31